CD44 and colorectal cancer: Collectively, the present study discovers that CD133+/CD44+ colorectal cancer stem cell-derived exosomal LINC01315 promotes the proliferation, migration, and stemness of colorectal cancer cells, providing novel biomarkers and targets for the research and treatment of colorectal cancer to some extent.